Page 11 - 2017 Impact | George Eastman Circle | University of Rochester
P. 11

Highlighted pledge totals include all gifts since the inception of the program.






                                                             HIGHLAND

                                                             HOSPITAL



                                                             •  The Hospital was again ranked as one of the top
                                                               hospitals in New York State and the region. The US
                                                               Centers for Medicare & Medicaid Services gave the
                                                               hospital a score of four out of five stars, which was
                                                               attained by only 12 hospitals in the state. Also, U.S.
                                                               News & World Report recognized Highland as a “Best
                                                               Regional Hospital,” a designation earned by less than 10
                                                               percent of nearly 5,000 hospitals in the country.

                                                             •  The Geriatric Fracture Center received the highest
                                                               recertification available, Premier Level Status, through
                                                               the International Geriatric Fracture Society CORE
          $1,222,108                                           Certification Program.
            Pledged
                                                             •  When the first phase of a 30,000-square-foot project on
                                                               the south side of the hospital was completed brand new,
                                                               state-of-the-art surgical rooms became fully operational.




                                                             WILMOT CANCER

                                                             INSTITUTE



                                                             •  The Institute continued to make advances in
                                                               immunotherapy, where progress is accelerating in
                                                               engaging the immune system to fight cancer. Wilmot
                                                               researchers are contributing to those advances, learning
                                                               more about the role of immune cells in cancer, studying
                                                               promising new therapies and developing novel ways to
                                                               improve immunotherapy.

                                                             •  The Blood and Marrow Transplant Program performed
                                                               its 3,000th transplant. Nearly a dozen new clinical trials
                                                               were opened for gynecologic cancers.

          $4,779,160                                         •  Investigators from the Institute presented their findings
            Pledged                                            at major national meetings held by the American Society
                                                               of Clinical Oncology and the American Society of
                                                               Hematology. Their studies included addressing side
                                                               effects of treatment with exercise, new biomarkers for
                                                               bile duct cancers, and improving treatment for chronic
                                                               lymphocytic leukemia, among other findings.
   6   7   8   9   10   11   12   13   14   15   16